메뉴 건너뛰기




Volumn 9, Issue 7, 2012, Pages

Antiretroviral therapy for prevention of tuberculosis in adults with hiv: A systematic review and meta-analysis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

EID: 84864447925     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001270     Document Type: Review
Times cited : (323)

References (98)
  • 2
    • 84864212488 scopus 로고    scopus 로고
    • Joint United Nations Programme on HIV/AIDS, Available, Accessed 23 November 2011
    • Joint United Nations Programme on HIV/AIDS (2011) World AIDS Day report 2011. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC2216_WorldAIDSday_report_2011_en.pdf. Accessed 23 November 2011.
    • (2011) World AIDS Day report 2011
  • 3
    • 84872365485 scopus 로고    scopus 로고
    • World Health Organization (2011) Global tuberculosis control 2011. Available: http://www.who.int/entity/tb/publications/global_report/2011/gtbr11_full.pdf. Accessed 14 October 2011.
  • 4
    • 36549042622 scopus 로고    scopus 로고
    • The United Nations, Available, Accessed 18 July 2011
    • The United Nations (2011) The Millenium Development Goals report. Available: http://mdgs.un.org/unsd/mdg/Resources/Static/Products/Progress2011/11-31339%20(E)%20MDG%20Report%202011_Book%20LR.pdf. Accessed 18 July 2011.
    • (2011) The Millenium Development Goals report
  • 5
    • 78650088377 scopus 로고    scopus 로고
    • Stop TB Partnership, Available, Accessed 7 February 2011
    • Stop TB Partnership (2010) The global plan to stop TB: 2011-2015. Available: http://www.stoptb.org/assets/documents/global/plan/TB_GlobalPlanToStopTB2011-2015.pdf. Accessed 7 February 2011.
    • (2010) The global plan to stop TB: 2011-2015
  • 6
    • 0036210480 scopus 로고    scopus 로고
    • Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries
    • Borgdorff MW, Floyd K, Broekmans JF, ((2002)) Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull World Health Organ 80:: 217--227.
    • (2002) Bull World Health Organ , vol.80 , pp. 217-227
    • Borgdorff, M.W.1    Floyd, K.2    Broekmans, J.F.3
  • 8
    • 77952549306 scopus 로고    scopus 로고
    • Tuberculosis control and elimination 2010-50: cure, care, and social development
    • Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, et al. ((2010)) Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 375:: 1814--1829.
    • (2010) Lancet , vol.375 , pp. 1814-1829
    • Lonnroth, K.1    Castro, K.G.2    Chakaya, J.M.3    Chauhan, L.S.4    Floyd, K.5
  • 9
    • 0032973632 scopus 로고    scopus 로고
    • Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection
    • De Cock KM, Chaisson RE, ((1999)) Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 3:: 457--465.
    • (1999) Int J Tuberc Lung Dis , vol.3 , pp. 457-465
    • de Cock, K.M.1    Chaisson, R.E.2
  • 13
    • 77953648371 scopus 로고    scopus 로고
    • Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources
    • Lawn SD, Wood R, De Cock KM, Kranzer K, Lewis JJ, et al. ((2010)) Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis 10:: 489--498.
    • (2010) Lancet Infect Dis , vol.10 , pp. 489-498
    • Lawn, S.D.1    Wood, R.2    de Cock, K.M.3    Kranzer, K.4    Lewis, J.J.5
  • 16
    • 79954493671 scopus 로고    scopus 로고
    • Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?
    • Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, et al. ((2011)) Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis 15:: 571--581.
    • (2011) Int J Tuberc Lung Dis , vol.15 , pp. 571-581
    • Lawn, S.D.1    Harries, A.D.2    Williams, B.G.3    Chaisson, R.E.4    Losina, E.5
  • 18
    • 68049137869 scopus 로고    scopus 로고
    • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
    • 10.1371/journal.pmed.1000100
    • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. ((2009)) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:: e1000100 doi:10.1371/journal.pmed.1000100.
    • (2009) PLoS Med , vol.6
    • Liberati, A.1    Altman, D.G.2    Tetzlaff, J.3    Mulrow, C.4    Gotzsche, P.C.5
  • 20
    • 69149102219 scopus 로고    scopus 로고
    • Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa
    • Lawn SD, Myer L, Edwards D, Bekker LG, Wood R, ((2009)) Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 23:: 1717--1725.
    • (2009) AIDS , vol.23 , pp. 1717-1725
    • Lawn, S.D.1    Myer, L.2    Edwards, D.3    Bekker, L.G.4    Wood, R.5
  • 21
    • 79952443080 scopus 로고    scopus 로고
    • Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies
    • Van Rie A, Westreich D, Sanne I, ((2011)) Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr 56:: 349--355.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , pp. 349-355
    • van Rie, A.1    Westreich, D.2    Sanne, I.3
  • 22
    • 28744451991 scopus 로고    scopus 로고
    • Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
    • Girardi E, Sabin CA, d'Arminio Monforte A, Hogg B, Phillips AN, et al. ((2005)) Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 41:: 1772--1782.
    • (2005) Clin Infect Dis , vol.41 , pp. 1772-1782
    • Girardi, E.1    Sabin, C.A.2    d'Arminio Monforte, A.3    Hogg, B.4    Phillips, A.N.5
  • 23
    • 80052203513 scopus 로고    scopus 로고
    • Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening
    • Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, et al. ((2011)) Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis 204:: 893--901.
    • (2011) J Infect Dis , vol.204 , pp. 893-901
    • Sterling, T.R.1    Lau, B.2    Zhang, J.3    Freeman, A.4    Bosch, R.J.5
  • 24
    • 77949510124 scopus 로고    scopus 로고
    • Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso
    • Dembele M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, et al. ((2010)) Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. Int J Tuberc Lung Dis 14:: 318--323.
    • (2010) Int J Tuberc Lung Dis , vol.14 , pp. 318-323
    • Dembele, M.1    Saleri, N.2    Carvalho, A.C.3    Saouadogo, T.4    Hien, A.D.5
  • 25
    • 77952955334 scopus 로고    scopus 로고
    • Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy
    • Lawn SD, Kranzer K, Edwards DJ, McNally M, Bekker LG, et al. ((2010)) Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy. AIDS 24:: 1323--1328.
    • (2010) AIDS , vol.24 , pp. 1323-1328
    • Lawn, S.D.1    Kranzer, K.2    Edwards, D.J.3    McNally, M.4    Bekker, L.G.5
  • 26
    • 77952326903 scopus 로고    scopus 로고
    • The population dynamics and control of tuberculosis
    • Dye C, Williams BG, ((2010)) The population dynamics and control of tuberculosis. Science 328:: 856--861.
    • (2010) Science , vol.328 , pp. 856-861
    • Dye, C.1    Williams, B.G.2
  • 28
    • 84860131403 scopus 로고    scopus 로고
    • The United Nations Development Programme, Available, Accessed 14 March 2012
    • The United Nations Development Programme (2011) Human development report. sustainability and equity: a better future for all. Available: http://hdr.undp.org/en/media/HDR_2011_EN_Complete.pdf. Accessed 14 March 2012.
    • (2011) Human development report. sustainability and equity: A better future for all
  • 29
    • 85100415918 scopus 로고    scopus 로고
    • The Cochrane Collaboration, Available, Accessed 19 April 2011
    • The Cochrane Collaboration (2011) Cochrane handbook for systematic reviews of interventions. Available: http://www.cochrane-handbook.org/. Accessed 19 April 2011.
    • (2011) Cochrane handbook for systematic reviews of interventions
  • 32
    • 21544443870 scopus 로고    scopus 로고
    • Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan
    • Seyler C, Toure S, Messou E, Bonard D, Gabillard D, et al. ((2005)) Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Am J Respir Crit Care Med 172:: 123--127.
    • (2005) Am J Respir Crit Care Med , vol.172 , pp. 123-127
    • Seyler, C.1    Toure, S.2    Messou, E.3    Bonard, D.4    Gabillard, D.5
  • 33
    • 78649375532 scopus 로고    scopus 로고
    • Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda
    • Nakanjako D, Mayanja-Kizza H, Ouma J, Wanyenze R, Mwesigire D, et al. ((2010)) Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. Int J Tuberc Lung Dis 14:: 1621--1628.
    • (2010) Int J Tuberc Lung Dis , vol.14 , pp. 1621-1628
    • Nakanjako, D.1    Mayanja-Kizza, H.2    Ouma, J.3    Wanyenze, R.4    Mwesigire, D.5
  • 34
    • 77952316931 scopus 로고    scopus 로고
    • A consistent log-linear relationship between tuberculosis incidence and body mass index
    • Lonnroth K, Williams BG, Cegielski P, Dye C, ((2010)) A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol 39:: 149--155.
    • (2010) Int J Epidemiol , vol.39 , pp. 149-155
    • Lonnroth, K.1    Williams, B.G.2    Cegielski, P.3    Dye, C.4
  • 35
    • 33746578047 scopus 로고    scopus 로고
    • The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
    • Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, et al. ((2006)) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368:: 505--510.
    • (2006) Lancet , vol.368 , pp. 505-510
    • Gilks, C.F.1    Crowley, S.2    Ekpini, R.3    Gove, S.4    Perriens, J.5
  • 36
    • 33750714476 scopus 로고    scopus 로고
    • HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations
    • Williams BG, Korenromp EL, Gouws E, Schmid GP, Auvert B, et al. ((2006)) HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. J Infect Dis 194:: 1450--1458.
    • (2006) J Infect Dis , vol.194 , pp. 1450-1458
    • Williams, B.G.1    Korenromp, E.L.2    Gouws, E.3    Schmid, G.P.4    Auvert, B.5
  • 37
    • 67650105676 scopus 로고    scopus 로고
    • Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection-a quantitative review
    • Korenromp EL, Williams BG, Schmid GP, Dye C, ((2009)) Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection-a quantitative review. PLoS ONE 4:: e5950 doi:10.1371/journal.pone.0005950.
    • (2009) PLoS ONE , vol.4
    • Korenromp, E.L.1    Williams, B.G.2    Schmid, G.P.3    Dye, C.4
  • 38
    • 49049099404 scopus 로고    scopus 로고
    • Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies
    • Wandel S, Egger M, Rangsin R, Nelson KE, Costello C, et al. ((2008)) Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex Transm Infect 84 (Suppl 1) (): i31--i36.
    • (2008) Sex Transm Infect , vol.84 , Issue.SUPPL. 1
    • Wandel, S.1    Egger, M.2    Rangsin, R.3    Nelson, K.E.4    Costello, C.5
  • 40
    • 0037098199 scopus 로고    scopus 로고
    • Quantifying heterogeneity in a meta-analysis
    • Higgins JP, Thompson SG, ((2002)) Quantifying heterogeneity in a meta-analysis. Stat Med 21:: 1539--1558.
    • (2002) Stat Med , vol.21 , pp. 1539-1558
    • Higgins, J.P.1    Thompson, S.G.2
  • 42
    • 0037097002 scopus 로고    scopus 로고
    • Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study
    • Badri M, Wilson D, Wood R, ((2002)) Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 359:: 2059--2064.
    • (2002) Lancet , vol.359 , pp. 2059-2064
    • Badri, M.1    Wilson, D.2    Wood, R.3
  • 44
    • 63149085640 scopus 로고    scopus 로고
    • Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort
    • Golub JE, Pronyk P, Mohapi L, Thsabangu N, Moshabela M, et al. ((2009)) Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS 23:: 631--636.
    • (2009) AIDS , vol.23 , pp. 631-636
    • Golub, J.E.1    Pronyk, P.2    Mohapi, L.3    Thsabangu, N.4    Moshabela, M.5
  • 45
    • 34250822376 scopus 로고    scopus 로고
    • The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil
    • Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, et al. ((2007)) The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 21:: 1441--1448.
    • (2007) AIDS , vol.21 , pp. 1441-1448
    • Golub, J.E.1    Saraceni, V.2    Cavalcante, S.C.3    Pacheco, A.G.4    Moulton, L.H.5
  • 46
    • 33748188042 scopus 로고    scopus 로고
    • Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients
    • Jerene D, Naess A, Lindtjorn B, ((2006)) Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Res Ther 3:: 10.
    • (2006) AIDS Res Ther , vol.3 , pp. 10
    • Jerene, D.1    Naess, A.2    Lindtjorn, B.3
  • 47
    • 59349102012 scopus 로고    scopus 로고
    • Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District
    • Lannoy LH, Cortez-Escalante JJ, Evangelista Mdo S, Romero GA, ((2008)) Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District. Rev Soc Bras Med Trop 41:: 549--555.
    • (2008) Rev Soc Bras Med Trop , vol.41 , pp. 549-555
    • Lannoy, L.H.1    Cortez-Escalante, J.J.2    Evangelista Mdo, S.3    Romero, G.A.4
  • 48
    • 41049101389 scopus 로고    scopus 로고
    • Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001
    • Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, et al. ((2007)) Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001. PLoS ONE 2:: e826 doi:10.1371/journal.pone.0000826.
    • (2007) PLoS ONE , vol.2
    • Miranda, A.1    Morgan, M.2    Jamal, L.3    Laserson, K.4    Barreira, D.5
  • 49
    • 79955694277 scopus 로고    scopus 로고
    • 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial
    • Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, et al. ((2011)) 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 377:: 1588--1598.
    • (2011) Lancet , vol.377 , pp. 1588-1598
    • Samandari, T.1    Agizew, T.B.2    Nyirenda, S.3    Tedla, Z.4    Sibanda, T.5
  • 50
    • 0037082984 scopus 로고    scopus 로고
    • Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy
    • Santoro-Lopes G, de Pinho AM, Harrison LH, Schechter M, ((2002)) Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis 34:: 543--546.
    • (2002) Clin Infect Dis , vol.34 , pp. 543-546
    • Santoro-Lopes, G.1    de Pinho, A.M.2    Harrison, L.H.3    Schechter, M.4
  • 51
    • 77954630522 scopus 로고    scopus 로고
    • Early versus standard antiretroviral therapy for HIV-infected adults in Haiti
    • Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, et al. ((2010)) Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 363:: 257--265.
    • (2010) N Engl J Med , vol.363 , pp. 257-265
    • Severe, P.1    Juste, M.A.2    Ambroise, A.3    Eliacin, L.4    Marchand, C.5
  • 52
    • 65649133108 scopus 로고    scopus 로고
    • Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database
    • Zhou J, Elliott J, Li PC, Lim PL, Kiertiburanakul S, et al. ((2009)) Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis 9:: 46.
    • (2009) BMC Infect Dis , vol.9 , pp. 46
    • Zhou, J.1    Elliott, J.2    Li, P.C.3    Lim, P.L.4    Kiertiburanakul, S.5
  • 53
    • 34249295234 scopus 로고    scopus 로고
    • Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention
    • Moulton LH, Golub JE, Durovni B, Cavalcante SC, Pacheco AG, et al. ((2007)) Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials 4:: 190--199.
    • (2007) Clin Trials , vol.4 , pp. 190-199
    • Moulton, L.H.1    Golub, J.E.2    Durovni, B.3    Cavalcante, S.C.4    Pacheco, A.G.5
  • 55
    • 84873634017 scopus 로고    scopus 로고
    • University of Minnesota Clinical and Translational Science Institute, Available, Accessed 5 August 2011
    • University of Minnesota Clinical and Translational Science Institute (2009) Strategic timing of antiretroviral treatment (START). Available: http://clinicaltrials.gov/ct2/show/NCT00867048. Accessed 5 August 2011.
    • (2009) Strategic timing of antiretroviral treatment (START)
  • 57
    • 38449116968 scopus 로고    scopus 로고
    • Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries
    • Brinkhof MW, Egger M, Boulle A, May M, Hosseinipour M, et al. ((2007)) Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clin Infect Dis 45:: 1518--1521.
    • (2007) Clin Infect Dis , vol.45 , pp. 1518-1521
    • Brinkhof, M.W.1    Egger, M.2    Boulle, A.3    May, M.4    Hosseinipour, M.5
  • 58
    • 41749086700 scopus 로고    scopus 로고
    • Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy
    • Lawn SD, Wilkinson RJ, Lipman MC, Wood R, ((2008)) Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 177:: 680--685.
    • (2008) Am J Respir Crit Care Med , vol.177 , pp. 680-685
    • Lawn, S.D.1    Wilkinson, R.J.2    Lipman, M.C.3    Wood, R.4
  • 59
    • 0004292914 scopus 로고    scopus 로고
    • Philadelphia, Lippincott Williams & Wilkins
    • Rothman K, Greenland S, Lash T, ((2008)) Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins.
    • (2008) Modern Epidemiology
    • Greenland, S.1    Lash, T.2
  • 60
    • 0033667445 scopus 로고    scopus 로고
    • Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature
    • Sterne JA, Gavaghan D, Egger M, ((2000)) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53:: 1119--1129.
    • (2000) J Clin Epidemiol , vol.53 , pp. 1119-1129
    • Sterne, J.A.1    Gavaghan, D.2    Egger, M.3
  • 61
    • 68049120239 scopus 로고    scopus 로고
    • Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure
    • Uy J, Armon C, Buchacz K, Wood K, Brooks JT, ((2009)) Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure. J Acquir Immune Defic Syndr 51:: 450--453.
    • (2009) J Acquir Immune Defic Syndr , vol.51 , pp. 450-453
    • Uy, J.1    Armon, C.2    Buchacz, K.3    Wood, K.4    Brooks, J.T.5
  • 62
    • 79960922334 scopus 로고    scopus 로고
    • World Health Organization, Available,. Accessed 8 November 2011
    • World Health Organization (2009) A practical handbook on the pharmacovigilance of antiretroviral medicines. Available: http://www.who.int/hiv/topics/pharmacovigilance/arv_pharmacovigilance_handbook.pdf. Accessed 8 November 2011.
    • (2009) A practical handbook on the pharmacovigilance of antiretroviral medicines
  • 63
    • 84860368504 scopus 로고    scopus 로고
    • Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011
    • Jordan MR, Bennett DE, Wainberg MA, Havlir D, Hammer S, et al. ((2012)) Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clin Infect Dis 54 (Suppl 4) (): S245--S249.
    • (2012) Clin Infect Dis , vol.54 , Issue.SUPPL. 4
    • Jordan, M.R.1    Bennett, D.E.2    Wainberg, M.A.3    Havlir, D.4    Hammer, S.5
  • 64
    • 79958703449 scopus 로고    scopus 로고
    • Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi
    • Zachariah R, Bemelmans M, Akesson A, Gomani P, Phiri K, et al. ((2011)) Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi. Int J Tuberc Lung Dis 15:: 933--937.
    • (2011) Int J Tuberc Lung Dis , vol.15 , pp. 933-937
    • Zachariah, R.1    Bemelmans, M.2    Akesson, A.3    Gomani, P.4    Phiri, K.5
  • 65
    • 79951805147 scopus 로고    scopus 로고
    • Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community
    • Middelkoop K, Bekker LG, Myer L, Johnson LF, Kloos M, et al. ((2011)) Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 56:: 263--269.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , pp. 263-269
    • Middelkoop, K.1    Bekker, L.G.2    Myer, L.3    Johnson, L.F.4    Kloos, M.5
  • 66
    • 77956057163 scopus 로고    scopus 로고
    • Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco
    • Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, et al. ((2010)) Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE 5:: e11068 doi:10.1371/journal.pone.0011068.
    • (2010) PLoS ONE , vol.5
    • Das, M.1    Chu, P.L.2    Santos, G.M.3    Scheer, S.4    Vittinghoff, E.5
  • 67
    • 84865742209 scopus 로고    scopus 로고
    • Stable incidence of HIV diagnoses among Danish MSM despite increased engagement in unsafe sex. J Acquir Immune Defic Syndr
    • Cowan SA, Gerstoft J, Haff J, Hartvig Christiansen A, Nielsen J, et al. ((2012)) Stable incidence of HIV diagnoses among Danish MSM despite increased engagement in unsafe sex. J Acquir Immune Defic Syndr. E-pub ahead of print doi:10.1097/QAI.0b013e31825af890.
    • (2012) E-Pub Ahead of Print
    • Cowan, S.A.1    Gerstoft, J.2    Haff, J.3    Hartvig Christiansen, A.4    Nielsen, J.5
  • 68
    • 77956056661 scopus 로고    scopus 로고
    • Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
    • Montaner JS, Lima VD, Barrios R, Yip B, Wood E, et al. ((2010)) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376:: 532--539.
    • (2010) Lancet , vol.376 , pp. 532-539
    • Montaner, J.S.1    Lima, V.D.2    Barrios, R.3    Yip, B.4    Wood, E.5
  • 69
    • 84872366622 scopus 로고    scopus 로고
    • Effect of ART coverage on rate of new HIV infections in a hyper-endemic, rural population: South Africa [abstract 136LB]
    • 5-8 March 2012; Seattle, Washington, United States
    • Tanser F, Bärnighausen T, Grapsa E, Newell M-L (2012) Effect of ART coverage on rate of new HIV infections in a hyper-endemic, rural population: South Africa [abstract 136LB]. 19th Conference on Retroviruses and Opportunistic Infections; 5-8 March 2012; Seattle, Washington, United States.
    • (2012) 19th Conference on Retroviruses and Opportunistic Infections
    • Tanser, F.1    Bärnighausen, T.2    Grapsa, E.3    Newell, M.-L.4
  • 70
    • 84864448204 scopus 로고    scopus 로고
    • Community viral load and newly reported HIV infections in Switzerland [IAS satellite session 17 July 2011]
    • 17-20 July 2011; Rome, Italy
    • Egger M (2011) Community viral load and newly reported HIV infections in Switzerland [IAS satellite session 17 July 2011]. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 17-20 July 2011; Rome, Italy.
    • (2011) 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention
    • Egger, M.1
  • 71
    • 58149097694 scopus 로고    scopus 로고
    • Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
    • Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG, ((2009)) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373:: 48--57.
    • (2009) Lancet , vol.373 , pp. 48-57
    • Granich, R.M.1    Gilks, C.F.2    Dye, C.3    de Cock, K.M.4    Williams, B.G.5
  • 72
    • 77349094313 scopus 로고    scopus 로고
    • Timing of initiation of antiretroviral drugs during tuberculosis therapy
    • Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, et al. ((2010)) Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 362:: 697--706.
    • (2010) N Engl J Med , vol.362 , pp. 697-706
    • Abdool Karim, S.S.1    Naidoo, K.2    Grobler, A.3    Padayatchi, N.4    Baxter, C.5
  • 73
    • 80054742528 scopus 로고    scopus 로고
    • Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis
    • Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al. ((2011)) Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 365:: 1471--1481.
    • (2011) N Engl J Med , vol.365 , pp. 1471-1481
    • Blanc, F.X.1    Sok, T.2    Laureillard, D.3    Borand, L.4    Rekacewicz, C.5
  • 74
    • 80054721877 scopus 로고    scopus 로고
    • Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
    • Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, et al. ((2011)) Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 365:: 1482--1491.
    • (2011) N Engl J Med , vol.365 , pp. 1482-1491
    • Havlir, D.V.1    Kendall, M.A.2    Ive, P.3    Kumwenda, J.4    Swindells, S.5
  • 75
    • 65449167169 scopus 로고    scopus 로고
    • Effect of early versus deferred antiretroviral therapy for HIV on survival
    • Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, et al. ((2009)) Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 360:: 1815--1826.
    • (2009) N Engl J Med , vol.360 , pp. 1815-1826
    • Kitahata, M.M.1    Gange, S.J.2    Abraham, A.G.3    Merriman, B.4    Saag, M.S.5
  • 76
    • 64349118898 scopus 로고    scopus 로고
    • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
    • Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, et al. ((2009)) Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373:: 1352--1363.
    • (2009) Lancet , vol.373 , pp. 1352-1363
    • Sterne, J.A.1    May, M.2    Costagliola, D.3    de Wolf, F.4    Phillips, A.N.5
  • 77
    • 79955422390 scopus 로고    scopus 로고
    • When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries
    • The HIV-CAUSAL Collaboration
    • The HIV-CAUSAL Collaboration ((2011)) When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries. Ann Intern Med 154:: 509--515.
    • (2011) Ann Intern Med , vol.154 , pp. 509-515
  • 78
    • 80053377142 scopus 로고    scopus 로고
    • Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters
    • The CASCADE Collaboration
    • The CASCADE Collaboration ((2011)) Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. Arch Intern Med 171:: 1560--1569.
    • (2011) Arch Intern Med , vol.171 , pp. 1560-1569
  • 79
    • 84857366408 scopus 로고    scopus 로고
    • Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence
    • Bärnighausen T, Tanser F, Dabis F, Newell ML, ((2012)) Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence. Curr Opin HIV AIDS 7:: 140--150.
    • (2012) Curr Opin HIV AIDS , vol.7 , pp. 140-150
    • Bärnighausen, T.1    Tanser, F.2    Dabis, F.3    Newell, M.L.4
  • 83
    • 79959325961 scopus 로고    scopus 로고
    • Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study
    • Sweat M, Morin S, Celentano D, Mulawa M, Singh B, et al. ((2011)) Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 11:: 525--532.
    • (2011) Lancet Infect Dis , vol.11 , pp. 525-532
    • Sweat, M.1    Morin, S.2    Celentano, D.3    Mulawa, M.4    Singh, B.5
  • 84
    • 77957872085 scopus 로고    scopus 로고
    • Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya
    • Lugada E, Millar D, Haskew J, Grabowsky M, Garg N, et al. ((2010)) Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS ONE 5:: e12435 doi:10.1371/journal.pone.0012435.
    • (2010) PLoS ONE , vol.5
    • Lugada, E.1    Millar, D.2    Haskew, J.3    Grabowsky, M.4    Garg, N.5
  • 85
    • 84858668831 scopus 로고    scopus 로고
    • Community-based multi-disease prevention campaigns for controlling HIV-associated tuberculosis
    • Suthar AB, Klinkenberg E, Ramsay A, Garg N, Bennett R, et al. ((2012)) Community-based multi-disease prevention campaigns for controlling HIV-associated tuberculosis. Int J Tuberc Lung Dis 16:: 430--436.
    • (2012) Int J Tuberc Lung Dis , vol.16 , pp. 430-436
    • Suthar, A.B.1    Klinkenberg, E.2    Ramsay, A.3    Garg, N.4    Bennett, R.5
  • 86
    • 79951622706 scopus 로고    scopus 로고
    • Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies
    • Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, et al. ((2011)) Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med 8:: e1000391 doi:10.1371/journal.pmed.1000391.
    • (2011) PLoS Med , vol.8
    • Getahun, H.1    Kittikraisak, W.2    Heilig, C.M.3    Corbett, E.L.4    Ayles, H.5
  • 88
    • 0027908070 scopus 로고    scopus 로고
    • Tuberculosis preventive therapy in HIV-infected individuals: a joint statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lung Disease (IUATLD)
    • Tuberculosis preventive therapy in HIV-infected individuals: a joint statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lung Disease (IUATLD). Wkly Epidemiol Rec 68:: 361--364.
    • Wkly Epidemiol Rec , vol.68 , pp. 361-364
  • 89
    • 84872365031 scopus 로고    scopus 로고
    • World Health Organization, Joint United Nations Programme on HIV/AIDS, Available,. Accessed 30 June 2010
    • World Health Organization, Joint United Nations Programme on HIV/AIDS (1998) Policy statement on preventive therapy against tuberculosis. Available: http://whqlibdoc.who.int/hq/1998/WHO_TB_98.255.pdf. Accessed 30 June 2010.
    • (1998) Policy statement on preventive therapy against tuberculosis
  • 90
    • 78649289257 scopus 로고    scopus 로고
    • Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme
    • Charalambous S, Grant AD, Innes C, Hoffmann CJ, Dowdeswell R, et al. ((2010)) Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme. AIDS 24 (Suppl 5) (): S5--S13.
    • (2010) AIDS , vol.24 , Issue.SUPPL. 5
    • Charalambous, S.1    Grant, A.D.2    Innes, C.3    Hoffmann, C.J.4    Dowdeswell, R.5
  • 91
    • 79954483529 scopus 로고    scopus 로고
    • Tuberculosis in HIV programmes in lower-income countries: practices and risk factors
    • Fenner L, Forster M, Boulle A, Phiri S, Braitstein P, et al. ((2011)) Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis 15:: 620--627.
    • (2011) Int J Tuberc Lung Dis , vol.15 , pp. 620-627
    • Fenner, L.1    Forster, M.2    Boulle, A.3    Phiri, S.4    Braitstein, P.5
  • 92
    • 84874720169 scopus 로고    scopus 로고
    • Impact of tuberculosis (TB) screening and isoniazid preventive therapy (IPT) on incidence of TB and death in the TB/HIV in Rio de Janeiro (THRio) study [abstract WELBB02]
    • 17-20 July 2011; Rome, Italy
    • Durovni B, Saraceni V, Pacheco A, Cavalcante S, Cohn S,et al. (2011) Impact of tuberculosis (TB) screening and isoniazid preventive therapy (IPT) on incidence of TB and death in the TB/HIV in Rio de Janeiro (THRio) study [abstract WELBB02]. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 17-20 July 2011; Rome, Italy.
    • (2011) 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention
    • Durovni, B.1    Saraceni, V.2    Pacheco, A.3    Cavalcante, S.4    Cohn, S.5
  • 93
    • 80055071244 scopus 로고    scopus 로고
    • Antiretroviral therapy in prevention of HIV and TB: update on current research efforts
    • Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, et al. ((2011)) Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res 9:: 446--469.
    • (2011) Curr HIV Res , vol.9 , pp. 446-469
    • Granich, R.1    Gupta, S.2    Suthar, A.B.3    Smyth, C.4    Hoos, D.5
  • 95
    • 33748039441 scopus 로고    scopus 로고
    • Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study
    • Podlekareva D, Mocroft A, Dragsted UB, Ledergerber B, Beniowski M, et al. ((2006)) Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study. J Infect Dis 194:: 633--641.
    • (2006) J Infect Dis , vol.194 , pp. 633-641
    • Podlekareva, D.1    Mocroft, A.2    Dragsted, U.B.3    Ledergerber, B.4    Beniowski, M.5
  • 96
    • 84859747108 scopus 로고    scopus 로고
    • Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries
    • The HIV-CAUSAL Collaboration
    • The HIV-CAUSAL Collaboration ((2012)) Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin Infect Dis 54:: 1364--1372.
    • (2012) Clin Infect Dis , vol.54 , pp. 1364-1372
  • 97
    • 84872364797 scopus 로고    scopus 로고
    • AIDS Clinical Trials Group, Available:,. Accessed 23 August 2011
    • AIDS Clinical Trials Group (2007) Appendix 60: diagnoses appendix. Available: http://www.hptn.org/web%20documents/HPTN052/Appendix60V1.123Feb2007.pdf. Accessed 23 August 2011.
    • (2007) Appendix 60: Diagnoses appendix
  • 98
    • 0025079350 scopus 로고
    • Diagnostic standards and classification of tuberculosis
    • American Thoracic Society
    • American Thoracic Society ((1990)) Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 142:: 725--735.
    • (1990) Am Rev Respir Dis , vol.142 , pp. 725-735


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.